About the New York Blood Center
Founded in 1964, New York Blood Center (NYBC) is a nonprofit organization that is one of the largest independent, community-based blood centers in the world. NYBC, along with its partner organizations Community Blood Center of Kansas City, Missouri (CBC), Innovative Blood Resources (IBR), Blood Bank of Delmarva (BBD), and Rhode Island Blood Center (RIBC), collect approximately 4,000 units of blood products each day and serve local communities of more than 45 million people in the Tri-State area (NY, NJ, CT), Mid Atlantic area (PA, DE, MD), the Kansas City metropolitan area, Minnesota, Nebraska, Rhode Island, and Southern New England. NYBC and its partners also provide a wide array of transfusion-related medical services, including Comprehensive Cell Solutions, the National Center for Blood Group Genomics, the National Cord Blood Program, and the Lindsley F. Kimball Research Institute, which — among other milestones — developed the Hepatitis B vaccine and a patented solvent detergent plasma process innovating blood-purification technology worldwide.
About Blood Bank of Delmarva
The Blood Bank of Delaware, as it was then known, was founded in 1954 as a non-profit, community-based blood center providing blood and blood products to hospitals and other organizations. In 1990, the organization merged with Blood Bank of the Eastern Shore to become Blood Bank of Delaware/Eastern Shore. In 2004 the organization changed its name to Blood Bank of Delmarva. Today, BBD serves 1.6 million people in New Castle, Kent and Sussex counties, Del.; Cecil County, Md.; Eastern Shore, Md. and Eastern Shore, Va. BBD is an FDA licensed a member of America’s Blood Centers and accredited by AABB.
About Community Blood Center
Community Blood Center (CBC), established over 40 years ago, serves hospitals in the Greater Kansas City metropolitan area, as well as eastern Kansas and western Missouri. CBC provides blood products to 70 area hospitals – and relies on volunteer donors each day to meet the need for life-saving gifts of blood. CBC provides high quality reference immunohematology laboratory services, including platelet and red blood cell antibody testing, and therapeutic apheresis to local hospitals.
About Comprehensive Cell Solutions
Comprehensive Cell Solutions builds on our excellence in science, research and development, medical services, laboratory services and blood. Today we offer a comprehensive menu of products and services to develop, improve, and implement scientific studies in the areas of regenerative medicine, cell therapies, transfusion medicine, and related scientific and medical endeavors. Our services provide access to our world-class clinical and scientific expertise.
Innovative Blood Resources is a non-profit community blood center that was formed in 2012 through the combination of two strong, nationally-recognized, community-based nonprofit blood centers: Minnesota-based Memorial Blood Center, and Nebraska Community Blood Bank. With a combined 100 years of blood industry experience, IBR provides comprehensive product and service capabilities focusing on value-driven solutions for patients, hospitals, physicians, researchers, and other health care partners.
IBR is also home to IBR Biomedical Services, which grew from the nationally recognized research and clinical trial contributions of Memorial Blood Centers' physicians and clinicians in blood banking and transfusion services. IBR Biomedical Services offers expertise in the areas of cellular therapy, clinical trial support, as well as regulatory and quality systems consulting.
About Lindsley F. Kimball Research Institute
Lindsley F. Kimball Research Institute (LFKRI) is the research branch of New York Blood Center. Since its establishment in 1964, LFKRI's research efforts have paved the way for new blood-related products, techniques and therapies. The Institute's commitment to ground-breaking research has resulted in numerous landmark patents and licenses. LFKRI’s areas of blood related research include transfusion medicine, hematology, infectious disease, epidemiology and cellular therapy.
About National Cord Blood Program
National Cord Blood Program (NCBP) was founded in 1992 to investigate cord blood as a possible solution to a critical public health need: finding appropriate hematopoietic progenitor cells for transplantation in patients who have no matched bone marrow donors. NCBP collects, processes, and stores cord blood units in liquid nitrogen freezers, ready for shipping whenever needed. Each unit is tested for the number of relevant cells. The unit and the donor’s mother are also tested for HLA type and transmissible infectious diseases. NCBP is the first cord blood bank to have a licensed cord blood product, HEMACORD®. NCBP is committed to providing high quality cord blood units and promoting high standards in cord blood banking.
About National Center for Blood Group Genomics
Built on a foundation of innovation and discovery and combining the scientific and research expertise of New York Blood Center and Community Blood Center of Kansas City, the National Center for Blood Group Genomics (NCBGG) specializes in applying precision medicine to blood transfusion to increase safety and minimize complications. Based in Kansas City, NCBGG’s mission is to provide the highest quality testing services for extended blood typing at lower cost for donor centers and the patients they serve to improve the practice of transfusion medicine, to develop the next generation of testing, and to train the next generation of leaders.
About Rhode Island Blood Center
The Rhode Island Blood Center (RIBC) was founded in 1979 as a nonprofit community blood center. For over 35 years, RIBC has been the primary supplier of blood and blood products to patients being cared for in hospitals throughout Rhode Island and in neighboring states. Our mission is to help save lives by ensuring a safe, plentiful and cost-effective blood supply. RIBC is also part of the National Marrow Donor Program and collects stem cells for transplant right at its Providence location. RIBC provides therapeutic treatments for patients in local hospitals. Its state-of-the-art laboratory conducts human leukocyte antigen (HLA) histocompatibility and red cell typing, immunogenics, as well as DNA and relationship testing. RIBC is also involved in a variety of local and national research programs in an effort to improve all aspects of the blood supply.